Home › Trial NCT07395804
How Darolutamide Plus Hormone Therapy Works for Men With Advanced Prostate Cancer in Everyday Medical Practice in Germany
- Trial IDNCT07395804
- StatusRecruiting
- PhaseN/A
- Study typeObservational
- SponsorBayer
- Enrollment500
- Start date2026-04-14
- ConditionsMetastatic Hormone-sensitive Prostate Cancer (mHSPC)
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.